Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis

Reference

1. 1.↵
   1. Marshall BC

   . Cystic Fibrosis Foundation Patient Registry: 2013. Annual Data Report. https://www.cff.org/2013_CFF_Patient_Registry_Annual_Data_Report.pdf. Accessed February 23, 2017.
2. 2.↵
   1. Schechter MS

   . Airway clearance applications in infants and children. Respir Care 2007;52(10):1382–1390; discussion 1390-1391.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Flume PA,
   2. Robinson KA,
   3. O'Sullivan BP,
   4. Finder JD,
   5. Vender RL,
   6. Willey-Courand DB,
   7. et al

   . Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522–537.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Eakin MN,
   2. Bilderback A,
   3. Boyle MP,
   4. Mogayzel PJ,
   5. Riekert KA

   . Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cystic Fibrosis 2011;10(4):258–264.

   OpenUrl
5. 5.↵
   1. Nasr SZ,
   2. Chou W,
   3. Villa KF,
   4. Chang E,
   5. Broder MS

   . Adherence to dornase α treatment among commercially insured patients with cystic fibrosis. J Med Econ 2013;16(6):801–808.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Briesacher BA,
   2. Quittner AL,
   3. Saiman L,
   4. Sacco P,
   5. Fouayzi H,
   6. Quittell LM

   . Adherence with tobramycin inhaled solution and health care utilization. BMC Pulm Med 2011;11(1):5.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Sawicki GS,
   2. Sellers DE,
   3. Robinson WM

   . High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cystic Fibrosis 2009;8(2):91–96.

   OpenUrl
8. 8.↵
   1. Kettler LJ,
   2. Sawyer SM,
   3. Winefield HR,
   4. Greville HW

   . Determinants of adherence in adults with cystic fibrosis. Thorax 2002;57(5):459–464.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Ball R,
   2. Southern KW,
   3. McCormack P,
   4. Duff AJ,
   5. Brownlee KG,
   6. McNamara PS

   . Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time. J Cystic Fibrosis 2013;12(5):440–444.

   OpenUrl
10. 10.↵
    1. Barker DH,
    2. Quittner AL

    . Parental depression and pancreatic enzymes adherence in children with cystic fibrosis. Pediatrics 2016;137(2):1–9. doi: 10.1542/peds.2015-2296.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Smith BA,
    2. Modi AC,
    3. Quittner AL,
    4. Wood BL

    . Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatric Pulmonol 2010;45(8):756–763.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Daniels T,
    2. Goodacre L,
    3. Sutton C,
    4. Pollard K,
    5. Conway S,
    6. Peckham D

    . Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011;140(2):425–432.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Arias Llorente RP,
    2. Bousoño García C,
    3. Díaz Martín JJ

    . Treatment compliance in children and adults with cystic fibrosis. J Cystic Fibrosis 2008;7(5):359–367.

    OpenUrl
14. 14.↵
    1. Myers LB,
    2. Horn SA

    . Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006;11(6):915–926.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Modi AC,
    2. Cassedy AE,
    3. Quittner AL,
    4. Accurso F,
    5. Sontag M,
    6. Koenig JM,
    7. Ittenbach RF

    . Trajectories of adherence to airway clearance therapy for patients with cystic fibrosis. J Pediatr Psychol 2010;35(9):1028–37.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. McIlwaine MP,
    2. Alarie N,
    3. Davidson GF,
    4. Lands LC,
    5. Ratjen F,
    6. Milner R,
    7. et al

    . Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax 2013;68(8):746–751.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Rosenstein BJ,
    2. Cutting GR

    . The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132(4):589–595.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Flume PA,
    2. Mogayzel PJ Jr.,
    3. Robinson KA,
    4. Goss CH,
    5. Rosenblatt RL,
    6. Kuhn RJ,
    7. et al

    . Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. American journal of respiratory and critical care medicine 2009;180(9):802–808.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Rabin HR,
    2. Butler SM,
    3. Wohl ME,
    4. Geller DE,
    5. Colin AA,
    6. Schidlow DV,
    7. et al

    . Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004;37(5):400–406.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Byrnes CA,
    2. Vidmar S,
    3. Cheney JL,
    4. Carlin JB,
    5. Armstrong DS,
    6. Cooper PJ,
    7. et al

    . Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax 2013;68(7):643–651.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Waters V,
    2. Ratjen F

    . Pulmonary exacerbations in children with cystic fibrosis. Ann Am Thorac Soc 2015;12(Suppl 2):S200–S206.

    OpenUrl
22. 22.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Hankinson JL,
    2. Odencrantz JR,
    3. Fedan KB

    . Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179–87.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Sabaté E

    . Adherence to long-term therapies: evidence for action. World Health Organization; 2003. http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdf. Accessed February 23, 2017.
25. 25.↵
    R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2016. https://www.R-project.org. Accessed February 23, 2017.
26. 26.↵
    1. Bender B,
    2. Wamboldt FS,
    3. O'Connor SL,
    4. Rand C,
    5. Szefler S,
    6. Milgrom H,
    7. Wamboldt MZ

    . Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000;85(5):416–421.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Modi AC,
    2. Marciel KK,
    3. Slater SK,
    4. Drotar D,
    5. Quittner AL

    . The influence of parental supervision on medical adherence in adolescents with cystic fibrosis: developmental shifts from pre to late adolescence. Child Health Care 2008;37(1):78–92.

    OpenUrlCrossRefWeb of Science
28. 28.↵
    1. Bishay LC,
    2. Sawicki GS

    . Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis. Adolesc Health Med Ther 2016;7:117–124.

    OpenUrl
29. 29.↵
    1. Hagel S,
    2. Reischke J,
    3. Kesselmeier M,
    4. Winning J,
    5. Gastmeier P,
    6. Brunkhorst FM,
    7. et al

    . Quantifying the Hawthorne effect in hand hygiene compliance through comparing direct observation with automated hand hygiene monitoring. Infect Control Hosp Epidemiol 2015;36(8):957–962.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. DiMatteo MR,
    2. Giordani PJ,
    3. Lepper HS,
    4. Croghan TW

    . Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40(9):794–811.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Burkhart PV,
    2. Dunbar-Jacob JM,
    3. Rohay JM

    . Accuracy of children's self-reported adherence to treatment. J Nurs Scholarsh 2001;33(1):27–32.

    OpenUrlCrossRefPubMedWeb of Science